ARTICLE
2020 Vision: Anything but Clear in the US
September 2020
Read time: 1 min
ARTICLE
September 2020
Read time: 1 min

ARTICLE / CLIENT ALERT
September 22, 2020
Read time: 9 min
On Sept. 18, 2020, the U.S. Department of Commerce (“Commerce Department”) issued its eagerly anticipated regulations under President Trump’s Aug. 6, 2020 Executive Orders (“E.O.s”) relating to the mobile applications (“apps”), WeChat and TikTok. As explained below, the regulations sharply restrict transactions involving either app within the United States, beginning on Sept. 20, 2020.[1] At the same time, the Commerce Department refrained from imposing sanctions on use of the apps outside the United States or on trading in the securities of WeChat’s and TikTok’s parent companies.
Both sets of regulations were scheduled to begin to take effect on Sept. 20, but due to subsequent developments in the courtroom and the boardroom, neither will. On Sept. 19, 2020, a federal judge in California granted a motion for a preliminary injunction which will — at least temporarily — curtail the government’s ability to implement the WeChat ban. And on the same day, following the announcement of a bid by Oracle Corp. (“Oracle”) for the U.S. operations of TikTok, the Commerce Department temporarily delayed implementation of the TikTok ban for one week.
The Aug. 6, 2020 E.O.s vest broad authority in the Commerce Department to prohibit persons subject to U.S. jurisdiction from engaging in transactions with the Chinese companies that own TikTok and WeChat.[2] E.O. 13942 targets ByteDance Ltd. (“ByteDance”), the owner of TikTok Inc. (“TikTok”); E.O. 13943 targets Tencent Holdings Ltd. (“Tencent”), the owner of WeChat.[3] According to the E.O.s, the apps pose a national security threat to the United States by virtue of the risk that personal and proprietary information captured from U.S. persons may be shared with the Chinese government. A later E.O., issued on Aug. 14, 2020, provides ByteDance 90 days to divest its interest in the U.S. operations of TikTok and thereby avoid certain sanctions.[4] This E.O. provided some hope that U.S. users of TikTok may continue to use the app if ByteDance successfully sells its U.S. TikTok operations by Nov. 12, 2020.
Both apps are widely used throughout the world, including in the United States. WeChat has become a vitally important tool in conducting business in China in particular, including among investment professionals. WeChat’s owner, Tencent, is a public company whose shares are widely traded. Under the E.O.s, the Commerce Department has the power to outlaw, to the fullest extent permitted by law, all transactions with ByteDance and all transactions with Tencent related to WeChat.[5] The E.O.s gave the Commerce Department 45 days — or until Sept. 20, 2020 — to decide what transactions would be prohibited, leaving many wondering exactly how far the Commerce Department would go.[6]
The Sept. 18, 2020 regulations represent the Commerce Department’s first — but not necessarily last — word on what types of transactions will be prohibited under the E.O.s.
The regulations targeting WeChat and TikTok are largely the same. They prohibit, “within the land and maritime borders of the United States and its territories,” the following transactions:
In addition, the regulations take aim at WeChat’s payment function by prohibiting any provision of services through the WeChat app for the purpose of transferring funds or processing payments within the United States.[8]
Although the substance of the prohibitions are essentially the same for both WeChat and TikTok, the implementation dates for each app vary. With respect to WeChat, all of the prohibitions were to take effect on Sept. 20, 2020. With respect to TikTok, only the first prohibition — on the provision of services to enable users in the United States to download or update the app — was to take effect on Sept. 20, 2020. The other prohibitions do not take effect until Nov. 12, 2020.[9]
Both sets of regulations expressly leave open the possibility that further transactions identified at a future time may also be prohibited.[10]
Equally notable are the transactions relating to WeChat and TikTok that are not prohibited under the Commerce Department’s regulations.
First, as noted above, all the prohibitions apply only “within the land and maritime borders of the United States and its territories.” They do not apply outside the United States, even to U.S. persons acting outside the United States. In other words, the Commerce Department chose not to exercise its authority under the E.O.s to extend the prohibitions to all “persons subject to U.S. jurisdiction,” wherever located.[11] This is unlike the economic sanctions administered by the Department of Treasury’s Office of Foreign Assets Control, which broadly apply to U.S. persons, wherever located, and in some instances, to activities abroad conducted by foreign companies owned or controlled by U.S. persons.
The Commerce Department regulations make this limitation explicit, stating that the prohibitions do not apply to “[a]ctivities related to mobile applications intended for distribution, installation or use outside of the United States, including but not limited to any person subject to U.S. jurisdiction, and all ancillary activities, including activities performed by any U.S. person, which are ordinarily incident to, and necessary for, the distribution, installation and use of mobile applications outside of the United States.”[12]
Second, the prohibitions apply only “to the parties to business-to-business transactions.”[13] They do not apply to “[t]he exchange between or among” users “of personal or business information using the [WeChat and TikTok] mobile application.”[14]
Third, the prohibitions are limited to the enumerated activities involving the WeChat and TikTok apps themselves. They do not prohibit other business dealings with Tencent or ByteDance or limit transactions or trading in their stock or other securities.
Finally, the regulations by their terms do not apply to: (1) the payment of wages, salaries and benefit packages to employees or contractors; or (2) the storing of TikTok or WeChat app user data in the United States.[15]
The regulation targeting TikTok also clarifies that nothing in it should be read to prohibit any transaction necessary to effectuate Tencent’s divestment of its interest in the U.S. operations of TikTok, set forth in the Aug. 14, 2020 E.O.[16]
Since the E.O.s were published in early August, several litigations have resulted, brought by, among others, an alliance of WeChat users. Following the announcement of regulations by the Commerce Department on Sept. 18, 2020, a federal judge in the U.S. District Court for the Northern District of California has granted a motion for a preliminary injunction which, at least for the time being, puts a nationwide freeze on the implementation of E.O. 13943 and halts the ban on the use of WeChat in the United States.[17] The court’s order details that the Plaintiffs have shown serious questions going to the merits of their First Amendment claim, which curtails the government’s ability to limit free speech.[18] It is likely that the government will appeal this order.
A similar action was filed by TikTok and Tencent on Sept. 18, 2020, but no decisions have yet been issued in that case.[19]
In addition, on Sept. 19, 2020, the Commerce Department delayed implementation of the TikTok regulations from Sept. 20 to Sept. 27, 2020, giving time for a deal to occur whereby Oracle would acquire TikTok’s U.S. operations.[20] This delay occurred immediately following President Trump’s tentative approval of the anticipated deal, which involves Oracle and Walmart joining together to form a new entity to purchase TikTok’s U.S. operations.[21] Under this contemplated deal, “Oracle will be responsible for key technology and security responsibilities to protect all U.S. user data.”[22] While it remains to be seen whether this deal will come to fruition, TikTok has bought itself some time to consummate a deal or, as noted above, curtail this ban in the courts.
Authored by Gary Stein and Hannah M. Thibideau.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] See Commerce Department, “Commerce Department Prohibits WeChat and TikTok Transactions to Protect the National Security of the United States” (Sept. 18, 2020), available here.
[2] E.O. 13942, “Addressing the Threat Posed by TikTok, and Taking Additional Steps To Address the National Emergency With Respect to the Information and Communications Technology and Services Supply Chain” (Aug. 6, 2020), available here; E.O. 13943, “Addressing the Threat Posed by WeChat, and Taking Additional Steps To Address the National Emergency With Respect to the Information and Communications Technology and Services Supply Chain” (Aug. 6, 2020), available here.
[3] Id.
[4] Regarding the Acquisition of Musical.ly by ByteDance Ltd., 85 Fed. Reg. 51,297 (Aug. 14, 2020), available here.
[5] See E.O. 13942 and E.O. 13943, supra note 2.
[6] Id.
[7] Commerce Department, “Identification of Prohibited Transactions to Implement Executive Order 13942 and Address the Threat Posed by TikTok and the National Emergency with Respect to the Information and Communications Technology and Services Supply Chain” (Sept. 18, 2020), available here; Commerce Department, “Identification of Prohibited Transactions to Implement Executive Order 13943 and Address the Threat Posed by WeChat and the National Emergency with Respect to the Information and Communications Technology and Services Supply Chain” (Sept. 18, 2020), available here.
[8] Id.
[9] Id.
[10] Id.
[11] See generally id.
[12] Id.
[13] Id.
[14] Id.
[15] Id.
[16] Identification of Prohibited Transactions to Address the Threat Posed by TikTok, supra note 7.
[17] U.S. WeChat Users Alliance v. Donald J. Trump, No. 20-cv-05910-LB (N.D. Cal Sept. 19, 2020) (Order Granting Motion for Preliminary Injunction).
[18] See id. at 16-18.
[19] TikTok Inc. v. Donald J. Trump, No. 20-cv-2658 (D.D.C. filed Sept. 18, 2020).
[20] Commerce Department, “Statement on Delayed Prohibitions Related to TikTok” (Sept. 19, 2020), available here.
[21] See U.S. Dep’t of Treasury, “Statement on TikTok from Treasury Spokesperson Monica Crowley” (Sept. 19, 2020), available here.
[22] Id.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.
ARTICLE
September 21, 2020
Read time: 1 min

ARTICLE / CLIENT ALERT
September 21, 2020
Read time: 8 min
On September 19, 2020, the US Department of Health and Human Services released updated guidance indicating how recipients of Provider Relief Fund (PRF) payments must account for and report lost revenues and expenses. PRF recipients must review this guidance, understand the impact of these new obligations and continue to monitor for evolving information as part of their ongoing compliance efforts.
On September 19, 2020, the US Department of Health and Human Services (HHS) released much-anticipated Provider Relief Fund (PRF) guidance articulating how lost revenues and expenses will be accounted for and addressing recipient reporting requirements. The guidance applies generally to PRF recipients that received one or more PRF payments exceeding $10,000 in the aggregate, but does not apply to the Nursing Home Infection Control distribution, the Rural Health Clinic Testing distribution, and reimbursement from the Health Resources and Services Administration (HRSA) Uninsured Program. It is imperative that PRF recipients consider the possible implications of this updated guidance, especially the manner in which HHS has articulated recipients may use PRF payments to cover “lost revenue.” Recipients should also continue to monitor the PRF FAQs guidance for additional clarifications on reporting requirements.
In Depth
The Provider Relief Fund (PRF) is funded through appropriations in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) and the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139). The CARES Act imposed certain reporting obligations on PRF recipients and authorized HHS to impose additional reporting and document retention requirements. In turn, the PRF Terms and Conditions (T&Cs), to which recipients must attest to keep their PRF payments, require recipients to submit reports on the use of the PRF funds as specified by the HHS Secretary. For an overview of the PRF distributions, see our MWE/M+ summary chart.
According to the new guidance, recipients will report on the use of their PRF payments by first submitting information on their healthcare-related expenses attributable to coronavirus for which another funding source is not financially responsible. This may include general and administrative (G&A) expenses and/or healthcare-related operating expenses.
Next, any PRF payment amounts that were not fully expended on healthcare-related expenses attributable to coronavirus are then applied to the provider’s “lost revenues,” now defined as the provider’s lost margin. In particular, the remaining PRF payments may be applied to offset the negative change in year-over-year net patient care operating income (patient care revenue less patient-care-related expenses), net of the healthcare-related expenses attributable to coronavirus calculated in step one. The guidance further notes that recipients that reported negative net operating income from patient care in 2019 may apply PRF amounts to lost revenues up to a net zero gain/loss in 2020.
Some observers may not have expected these clarifications because HHS repeatedly referred to “lost revenues” generally in previous guidance, and the term “lost revenues” is now being defined inconsistently with the common meaning of the term (i.e., as lost income/margin). The CARES Act statutory text and Terms and Conditions for the affected distributions simply refer to “lost revenues” and prior guidance suggested a more standard definition of “lost revenues.” It is worth noting, however, that if lost revenues could have been applied to expenses irrespective of the impact on margin, this would have introduced the possibility of PRF funding making a healthcare provider more profitable in 2020 than it was in 2019, depending on whether that recipient reduced its expenses. This development could lead to legal challenges of HHS’ definition of “lost revenues” in the PRF program, particularly given the sub-regulatory nature of the definition.
If recipients do not expend their PRF funds in full by the end of calendar year 2020, they will have an additional six months to use the remaining amounts. The extra six-month reporting period (January–June 2021) will be compared to the same period in 2019 for the purposes of making calculations.
The updated guidance does not cover auditing requirements. More information regarding applicable auditing requirements can be found in the PRF FAQs guidance and in our MWE/M+ summary chart.
Data Elements
Under the new guidance, recipients will be required to report several data elements, including demographic information, information about their expenses attributable to coronavirus, information about their lost revenues and additional (non-financial) information. Recipients also must report information on changes in ownership and their Single Audit status (if known at the time of reporting).
Recipients that received between $10,000 and $499,999 in aggregated PRF payments must report healthcare-related expenses attributable to coronavirus (net of other reimbursed sources) in two aggregated categories: (1) general and administrative (G&A) expenses and (2) other healthcare-related expenses. Recipients that received $500,000 or more in PRF payments are required to report healthcare-related expenses attributable to coronavirus (net of other reimbursed sources) by reporting more detailed information within those two categories, according to several sub-categories enumerated in the guidance.
Recipients must also provide information on their lost revenues attributable to coronavirus. First, recipients will report information on their total revenue/net charges from patient-care-related sources for calendar years 2019 and 2020. Recipients with unused funds after December 31, 2020, will later submit additional information that includes patient-care-related revenue amounts earned between January 1 and June 30, 2021. Recipients will report this revenue information by payer type. Recipients will also be required to report information on other assistance they received in 2020.
Finally, HHS will require recipients to submit certain non-financial data. This information will include metrics on personnel, patients and facilities. Recipients that acquired or divested of related subsidiaries must also submit information regarding that change in ownership. Recipients must also report whether they are subject to Single Audit requirements in 2020. If so, they must report whether their PRF payments were selected as within the scope of their Single Audit (if the recipient knows this information at the time of reporting).
Deadlines
The updated guidance did not explicitly revise the deadlines articulated in the previous guidance released on July 20, 2020, except to say that the reporting portal will be available in early 2021 (instead of on October 1, 2020). The other deadlines appear to remain unchanged. However, as with previous PRF deadlines, these deadlines may be adjusted as the reporting mechanism is implemented. Important reporting deadlines are highlighted below:
CARES Act Section 15011 Reporting Requirements
In addition, Section 15011 of the CARES Act (and the PRF T&Cs) requires recipients of more than $150,000 in total funds appropriated under the CARES Act, the Families First Coronavirus Response Act (P.L. 116-127), or any other Act “primarily making appropriations for the coronavirus response and related activities” to submit a report to HHS and the Pandemic Response Accountability Committee within ten (10) days following the end of each calendar quarter. HHS previously indicated that PRF recipients’ reporting obligations under Section 15011 of the CARES Act are satisfied by HHS’s public reporting on the identity of PRF recipients and the amount of PRF funds received.
The September 19, 2020, updated guidance did not provide further clarification on whether HHS’s public reporting will continue to satisfy the Section 15011 requirement and did not further specify how (or whether) the reporting information announced in the guidance relates to the Section 15011 requirement. Recipients should continue to monitor the PRF website and guidance for updates on the Section 15011 requirement and any future PRF reporting details. For now, the updated guidance provides important details for recipients who will need to submit reports in 2021 on their use of the PRF funds.
Conclusion
Ensuring Provider Relief Fund payments are spent appropriately is likely to remain a high priority for HHS. As developments regarding lost revenue calculations reporting demonstrate, recipients should closely monitor evolving Provider Relief Fund guidance to support their ongoing compliance efforts and should examine the possible implications of this updated reporting guidance.

ARTICLE / CLIENT ALERT / US POLICY
September 21, 2020
Read time: 9 min
On Aug. 26, 2020, the SEC promulgated final rule amendments (“Final Rule”)[1] that, among other things, broaden the definitions of “accredited investor” (“AI”) in SEC Regulation D under the Securities Act of 1933 (“’33 Act”) and “qualified institutional buyer” (“QIB”) in SEC Rule 144A. The AI definition is key in determining who is eligible to participate, under the safe harbor contained in Rule 506 of Regulation D, in offerings of securities not subject to registration under the ’33 Act. The exemption afforded by Regulation D is widely relied upon by private fund managers as well other types of issuers.
The Final Rule largely reflects the SEC’s December 2019 proposal,[2] and is primarily a collection of gap-filling amendments. Nevertheless, these changes should be understood by all private fund managers that rely on Regulation D or who advise on transactions that require participants to make QIB representations, if only because these amendments likely will require changes to fund subscription documentation.
The Final Rule will be effective 60 days following its publication in the Federal Register (i.e., effective date likely to be prior to the end of 2020).
The Final Rule adds to SEC Rule 501(a) two new categories of natural person AIs and several new categories of qualifying entities. These represent a modest expansion of the types of investors that qualify as AIs.
In parallel to its updates to the AI definition, the SEC has adopted conforming changes to various other rules. Most notably, the definition of “qualified institutional buyer” under Rule 144A has been amended to include any institutional AI as defined under Rule 501(a) (provided that such entities satisfy the $100 million in securities owned and invested test).
At a minimum, private fund managers should review the SEC’s revised definitions to identify necessary updates to their subscription documents (such as the text of AI questionnaires) in light of the SEC’s rule changes. We have revisions ready for our forms of subscription documents.
Private fund managers may also wish to consider the following practical points:
A few notable topics raised in the proposed amendments that clients may have been following were discussed in the SEC commentary accompanying the final amendments but not adopted:
Authored by David Nissenbaum and Joshua B. Wright.
If you have any questions concerning this Alert or wish to update your subscription agreements or internal policies, please contact your attorney.

ARTICLE
September 18, 2020
Read time: 3 min
McDermott hosted James McGinnis, managing director at PJ Solomon, and Salvo Vitale, country manager at US Wind, on September 17 for an interactive discussion on the US offshore wind market.
Below are key takeaways from this week’s webinar.

ARTICLE
September 16, 2020
Read time: 2 min
We are pleased to be featured in the ninth issue of M&A Review highlighting our upcoming conference, MuMAC 2020: M&A in Pandemic Times. The feature contains a number of articles by our McDermott lawyers and other industry experts, delving into various aspects of cross border M&A during these unprecedented times.

ARTICLE / CLIENT ALERT
September 16, 2020
Read time: 14 min
On September 1, 2020, the US Department of the Treasury (Treasury) and Internal Revenue Service (IRS) released final regulations on the base erosion and anti-abuse tax (the BEAT) under section 59A. These regulations finalize proposed section 59A regulations issued in December 2019 (the Proposed Regulations), with certain modifications. This discussion addresses several key topics of the final regulation package (the Final Regulations), which includes the BEAT deduction waiver election, adjustments to the basis step-up anti-abuse rule in Treas. Reg. § 1.59A-9(b)(4), and the determination of a taxpayer’s aggregate group.
BEAT Deduction Waiver Election
The centerpiece of the Proposed Regulations was the inclusion of a deduction waiver election (the “Waiver Election”) to help taxpayers manage the base erosion percentage. The BEAT statutory language creates a cliff effect, in that a small amount of deductions can tip a taxpayer over the 3% base erosion percentage threshold, causing the BEAT to apply even to base erosion payments that were under the threshold. The Waiver Election addresses this problem by allowing a taxpayer to forgo a deduction on an item-by-item basis to keep the base erosion percentage below the 3% threshold. While some sort of deduction waiver ability would have existed anyway under general case law, the provision of an IRS-approved framework for deduction waiver, with specific terms and procedures, was a very welcome development. While waiving deductions is generally a costly solution to a BEAT problem, the ability to do so helps taxpayers sleep at night knowing that a future discovery of previously unknown deductible payments will not trigger disproportionate BEAT consequences. The Proposed Regulations would allow a taxpayer to waive deductions on an original or an amended return, or even on audit. Under the Proposed Regulations, deduction waiver operates as a one-way ratchet—a taxpayer can increase the amount of deductions waived, but once waived cannot reduce the amount of the waiver. The Final Regulations generally adopt the Waiver Election provisions of the Proposed Regulations, but provide clarification on certain points and address comments in several notable areas. Commenters had requested greater flexibility in applying the election, but these requests were rejected.
Comments requested that taxpayers be allowed to reduce the amount of a previous deduction waiver. For example, if a taxpayer overestimated the amount of deductions that they needed to waive to reduce the base erosion percentage to below 3%, a maximally flexible approach would be to allow the taxpayer to reduce the extent of their previous waiver and thereby obtain the regular tax benefit of the deductions that the taxpayer ultimately had no need to waive. The Final Regulations did not adopt this approach, based on concerns about adding to the complexity of audits. Thus, the Waiver Election remains a one-way ratchet. As a result, taxpayers should carefully, and conservatively, estimate the amount of the deductions they wish to waive, because they will not be able to take deductions back once they decide to waive them. Relevant to this issue, the Final Regulations clarify that a deduction may be waived in part, as opposed to in full. The Proposed Regulations had implied that a partial waiver was possible in discussing certain rules, but did not explicitly state that it was allowed. The Final Regulations’ clarification is favorable, because allowing partial waivers can help taxpayers refine the amount of deductions needed to be waived to avoid the cliff, while ensuring that the remaining deductions are not wasted. At the same time, taxpayers need to be mindful of the Waiver Election’s procedures, as the option to elect or increase the deduction waiver on audit is available only under general IRS procedures for submitting affirmative adjustments and thus may be available only very early in the audit (although the safety valve of electing or increasing a deduction waiver via amended return is available even well into an audit, as long as the statute of limitations is kept open).
The Final Regulations also address comments that requested that taxpayers that made elections to capitalize and amortize research and experimentation expenditures (R&E) for purposes of BEAT, as well as electing to not claim bonus depreciation, be entitled to automatic relief on revoking such elections. Additionally, comments requested that taxpayers be allowed to retroactively make the elections to capitalize and amortize R&E or not claim bonus depreciation to provide relief from permanent BEAT consequences. The Final Regulations reject both proposals, citing concern that it would permit taxpayers to use hindsight to reduce or eliminate BEAT liability or regular income tax.
The Final Regulations make several modifications to the Waiver Election in the context of partnerships. For example, the regulations permit a corporate partner to make the Waiver Election with respect to partnership items and clarify that a partnership may not make an election. This change is helpful, as partners may have differing circumstances with respect to BEAT and an election benefiting one might have negative consequences for others. The Final Regulations also provide certain rules to conform the partner-level waiver with section 163(j). Further, the regulations provide that waived deductions are treated as nondeductible expenditures, thereby reducing the adjusted basis of a partner’s interest in a partnership. In this regard, the regulations made a similar revision for consolidated groups, by clarifying that waived deductions attributable to a consolidated group member are treated as noncapital, nondeductible expenses that decrease the tax basis in the member’s stock for purposes of the stock basis rules in Treasury Regulation section 1.1502-32.
Basis Step-Up Anti-Abuse Rule
The Final Regulations also provide some needed relief to taxpayers by narrowing the anti-abuse rule in Treas. Reg. § 1.59A-9(b)(4) with respect to basis step-up transactions that precede inbound nonrecognition transactions involving depreciable and amortizable property (the “Basis Step-Up Anti-Abuse Rule”).
As background, base erosion payments generally include amounts paid or accrued by a corporate US taxpayer to a related foreign party in exchange for depreciable or amortizable property. The final 2019 BEAT regulations adopted a limited exception that generally excludes from the definition of a base erosion payment transfers or exchanges of stock made in connection with an inbound corporate nonrecognition transaction. Thus, any transfers or exchanges of stock by a corporate US taxpayer to a related foreign party in exchange for depreciable or amortizable property in connection with a section 351 exchange, a section 332 liquidation, a section 355 spin-off, or a section 368 reorganization generally do not give rise to base erosion payments (the “Nonrecognition Transaction Exception”). As a result, any future depreciation or amortization deductions claimed by the corporate US taxpayer on property received as part of the inbound nonrecognition transaction do not give rise to base erosion tax benefits for purposes of calculating potential BEAT liability.
The 2019 BEAT regulations also introduced the Basis Step-Up Anti-Abuse Rule. As initially finalized in 2019, this rule provided that if a transaction, plan, or arrangement had a principal purpose of increasing the basis of depreciable or amortizable property that a corporate US taxpayer later received as part of an inbound nonrecognition transaction, the Nonrecognition Transaction Exception was completely turned off. The anti-abuse rule also included an irrebuttable presumption that transaction, plan, or arrangement had such a tainted principal purpose if it: (i) was between related parties; (ii) occurred within the six-month period before an inbound nonrecognition transaction; and (iii) increased the depreciable or amortizable basis of property the corporate US taxpayer would acquire as part of the inbound nonrecognition transaction.
The scope of the initial version of the Basis Step-Up Anti-Abuse Rule was criticized as being overly broad and too vague. Treasury and the IRS recognized some of these concerns and, as indicated above, made taxpayer-favorable changes to the anti-abuse rule as part of the recent 2020 BEAT regulation package.
First, as initially finalized, the Basis Step-Up Anti-Abuse Rule created a new cliff effect that disqualified otherwise pre-existing basis in depreciable or amortizable property. For instance, under the initial version of the rule, if one week before an inbound section 332 liquidation, the liquidating foreign corporation purchased depreciable property from a related foreign party for $100x (which created only $5x of gain for the selling foreign related party and thus only $5x of basis step-up), all of the stock treated as exchanged by the corporate US taxpayer for the depreciable property worth $100x as part of the subsequent inbound section 332 liquidation would have been disqualified from falling within the Nonrecognition Transaction Exception, thus resulting in a base erosion payment based on the Basis Step-Up Anti-Abuse Rule.
In the new Final Regulations, Treasury and the IRS removed the cliff effect from the Basis Step-Up Anti-Abuse Rule. Under the modified version of the rule, only the stock treated as exchanged by the corporate US taxpayer that is attributable to the incremental increase in basis in the depreciable or amortizable property that occurred as part of the preceding taxable transaction will be disqualified from falling within the Nonrecognition Transaction Exception. Thus, based on the example above, under the updated version of the Basis Step-Up Anti-Abuse Rule, $95x of the $100x of stock exchanged by the corporate US taxpayer in the section 332 liquidation would fall within the Nonrecognition Transaction Exception (and thus not give rise to a base erosion payment) with the remaining $5x falling within the anti-abuse rule and giving rise to a base erosion payment. As illustrated by the example, this change to the anti-abuse rule should provide greater flexibility when planning into inbound nonrecognition transactions, because pre-existing depreciable or amortizable basis will not be counted for purposes of calculating any future BEAT liabilities.
Second, as initially finalized, there was confusion as to the potential reach of the Basis Step-Up Anti-Abuse Rule. For instance, some corporate US taxpayers were unclear whether an unrelated section 338(g) election that occurred years prior to an inbound nonrecognition transaction, which created basis that was still being depreciated or amortized by the corporate US taxpayer who received the property as part of the inbound nonrecognition transaction, was subject to the anti-abuse rule. To allay these concerns, Treasury and the IRS clarified that the transaction, plan, or arrangement with a principal purpose of increasing the adjusted basis of depreciable or amortizable property must have a factual connection with the acquisition of such property by the corporate US taxpayer as part of the subsequent inbound nonrecognition transaction. This change should provide corporate US taxpayers with greater confidence as to which basis step-up transactions are or will be subject to the Basis Step-Up Anti-Abuse Rule.
In summary, as before the changes to the Basis Step-Up Anti-Abuse rule, corporate US taxpayers generally should remain comfortable that basis step-up transactions involving an unrelated party that precede an inbound nonrecognition transaction should not be subject to the anti-abuse rule. However, even if related parties are involved, with the removal of the cliff effect from the Basis Step-Up Anti-Abuse rule, corporate US taxpayers should have greater flexibility when planning into nonrecognition transactions without having to take into account pre-existing depreciable or amortizable basis for purposes of computing future BEAT liabilities.
Taxpayers Which Are Members of an Aggregate Group
The Final Regulations address several issues relevant to determining a taxpayer’s “aggregate group” and which items of its group members are taken into account. The concept of aggregate group begins with the definition of a “controlled group” under section 1563(a), with some modifications (including the use of a “more than 50 percent” threshold rather than “at least 80 percent”). Clarification of precisely which corporations are members of a taxpayer’s aggregate group is essential because the gross receipts tests and base erosion percentage test are applied on the basis of the taxpayer’s aggregate group. Therefore, whether the taxpayer is ultimately subject to the BEAT hinges on which entities are included within that aggregate group.
In particular, the Final Regulations address issues regarding members with short taxable years, members joining or leaving the taxpayer’s aggregate group, and how to deal with predecessor corporations.
Under the new Final Regulations, a taxpayer measures the gross receipts and base erosion percentage of its aggregate group by reference to the taxpayer’s gross receipts, base erosion tax benefits, and deductions for the taxable year, and the gross receipts, base erosion tax benefits, and deductions for the taxable year of each member of its aggregate group which ends with or within the taxpayer’s taxable year (the “with-or-within method”).
In the event that the taxpayer has a short year, one or more of the members of its aggregate group may have a taxable year that does not end with or within the taxpayer’s. This could lead to an undercounting of items of a taxpayer’s aggregate group. The Final Regulations adopt the provisions in the Proposed Regulations requiring taxpayers to use a “reasonable approach” to determine the gross receipts and base erosion percentage of its aggregate group members. A reasonable approach must not over- or under-count the items of the taxpayer’s aggregate group. In particular, the Final Regulations state that simply excluding items of a member whose taxable year does not end with or within the taxpayer’s taxable year is not a reasonable approach. Beyond that, the Final Regulations include several examples of methods that may or may not be reasonable.
i. Close of taxable year rule for determining gross receipts and base erosion percentage
When a corporation joins or leaves a taxpayer’s aggregate group during a taxable year, the taxpayer must take into account the corporation’s items only for the period during the taxpayer’s taxable year for which the corporation was a member.
The new Final Regulations largely adopt unchanged the method described in the Proposed Regulations for part-year members. First, when a corporation joins or leaves the aggregate group, its taxable year is deemed to end. The Final Regulations state that the corporation’s taxable year ends at the end of the day on which the corporation joins or leaves the aggregate group. This is a change from the Proposed Regulations that had the deemed taxable year-end occur immediately. This change was adopted to better align the regulations with other provisions of the Internal Revenue Code and regulations (e.g., section 381 and Treas. Reg. § 1.1502-76).
Generally, the taxpayer must either use a close of the books method or a pro rata allocation of the corporation’s items to take into account the period during which the corporation was a member. If a close of the books method is used, there is a special rule that treats any “extraordinary items” after the corporation joins or leaves the group but on the same day as occurring the next day. The Final Regulations also extend the definition of extraordinary items beyond those described in Treas. Reg. §1.1502-76(b)(2)(ii)(C) to any other payment that is not made in the ordinary course of business and that would be treated as a base erosion payment.
ii. Aggregate group members with different taxable years leading to over- and under-counting of gross receipts
Often a corporation leaving or joining an aggregate group also creates a short tax year as a result of the deemed taxable year-end. Commentators highlighted the fact that in such a situation the combination of the with-or-within method and a close of the books created an over-counting issue when the member and the taxpayer have different tax years. For example, consider a taxpayer with a calendar taxable year and a member of the taxpayer’s group with a June 30 taxable year-end. If that member leaves the aggregate group on November 30, as a result of the with-or-within rule, the taxpayer must include the full 12-month taxable year of the member that ends on June 30 plus the short 5-month taxable year of the member that is deemed to end on November 30. Thus, the taxpayer would have to include 17 months of the member’s items.
To address this, the Final Regulations adopt an annualization concept. If a member of the taxpayer’s aggregate group has more than one taxable year that ends with or within the taxpayer’s taxable year, then the taxpayer annualizes that member’s items by multiplying by a factor of 365 divided by the number of days in that member’s taxable years included. The Final Regulations also adopt a reciprocal concept when a member changes its taxable year and as a result the member’s taxable year(s) that end with or within the taxpayer’s are composed of fewer than 12 months.
Regarding predecessor corporations, the new Final Regulations largely adopt the Proposed Regulations that stated that a reference to a taxpayer included a reference to a predecessor of that taxpayer, to include distributor or transferor corporation in a section 381(a) transaction. The new Final Regulations also adopted the language from the Proposed Regulations that provided that if a predecessor of the taxpayer were a member of the taxpayer’s aggregate group, then the items of each member are taken into account only once.
The Final Regulations extend this preference against over-counting by requiring a taxpayer to take into account gross receipts of a foreign predecessor only to the extent that the gross receipts are taken into account in determining income effectively connected with a US trade or business.

ARTICLE / CLIENT ALERT
September 16, 2020
Read time: 8 min
On September 13, 2020, the White House issued an Executive Order titled “Lowering Drug Prices by Putting America First” (the Executive Order), which directed the Secretary of the US Department of Health and Human Services (the Secretary) to implement payment models pursuant to which Medicare would pay no more than the “most-favored-nation price” for certain Part B and Part D drugs and biologics. If implemented, such payment models could transform the drug and biological reimbursement landscape. However, because the models will require implementation through the formal rulemaking process, their path to actual implementation is highly uncertain, and the Executive Order will not result in short-term changes.
The Executive Order
The White House announced on July 24, 2020, that it would issue an executive order to ensure the United States pays the lowest price available in economically comparable countries for Medicare Part B drugs. However, President Trump indicated he would delay issuing the Executive Order, pending discussions with pharmaceutical executives on the subject.
After those discussions proved unfruitful, President Trump issued the Executive Order on September 13, 2020, directing the Secretary to take appropriate steps to implement payment-model demonstrations pursuant to which Medicare would pay no more than the “most-favored-nation price” for certain prescriptions and biological products under both Medicare Part B and Medicare Part D. The most-favored-nation price means the lowest price, adjusted for volume and differences in national gross domestic product (GDP), for a pharmaceutical product that the drug manufacturer sells in a member country of the Organisation for Economic Co-operation and Development that has a comparable per capita GDP. Notably, the Executive Order alone does not establish the payment models; rather, it directs the Secretary to “take appropriate steps,” “to the extent consistent with law,” to develop and implement rulemaking to test the models.
More specifically, the Executive Order directs the Secretary to “immediately take appropriate steps to implement his rulemaking plan” for the Part B payment model, likely referencing the International Pricing Index (IPI) Model that was proposed in a 2018 Advance Notice of Proposed Rulemaking and for which a Proposed Rule has been under review at the Office of Management and Budget since June 2019. (For more information on the IPI Model, please refer to our summary materials at “CMS Requests Comment on Potential International Pricing Index Model for Part B Drugs” and “The International Pricing Index Model: Breaking Down CMS’s Proposed Drug Pricing Model”). Although the Trump administration has not previously included Medicare Part D in its international reference pricing proposals, the Executive Order also directs the Secretary to “take appropriate steps to develop and implement a rulemaking plan” for a payment model for Part D prescription drugs and biological products, which constitute a larger share of drug spending compared to Medicare Part B.
Analysis
The Executive Order is the culmination of years-long discussions and posturing as the Trump administration has sought to take meaningful steps to reduce the prices of prescription drugs in the United States. Although Congress has introduced legislation to address drug pricing, the bills have not gained necessary bipartisan support to move forward. In the absence of drug price legislation, the Trump Administration was left with a limited number of relatively narrow opportunities to meaningfully address drug pricing.
The Medicare payment model demonstration authority was one such vehicle. If implemented as previously described by the Centers for Medicare and Medicaid Services (CMS) and particularly if expanded to Part D drugs, the IPI Model would make sweeping changes to the drug and biological supply chain and pose a variety of expected and unknown implications for drug and biological manufacturers, distributors, group purchasing organizations, hospitals, physician clinics and pharmacies, among other industry stakeholders.
Significant uncertainties remain as to whether this attempt at restructuring the drug pricing landscape has any chance of proceeding given the rulemaking timeline and whether President Trump will be elected for a second term. However, it is noteworthy that the Administration and House Democrats have proposed similar IPI drug pricing models. Stakeholders should expect to continue to see legislative and regulatory proposals in 2021 that consider some form of international reference price no matter who is elected President.
If CMS decides to move forward with rulemaking for either the Part B or Part D drug payment models, the rulemaking process would offer the public another opportunity to comment on the various complexities of the payment model demonstration. Public responses, as well as various political and regulatory considerations, have the potential to influence whether or how CMS will decide to proceed in implementing the Executive Order.
ARTICLE
September 15, 2020
Read time: 1 min